Abstract
Alzheimer’s Disease (AD), a disorder of unknown etiology, is the most common form of adult-onset dementia and is characterized by severe intellectual deterioration. The definitive diagnosis of AD is made by postmortem examination of the brain, which reveals large quantities of neurofibrillary tangles (NFT) and senile plaques within the parenchyma. The NFT are composed of paired helical filaments associated with several cytoskeletal proteins. The primary protein component of senile plaques is β/A4 amyloid, a 42–43 amino acid peptide derived from a much larger molecule, the amyloid precursor protein (APP). Vascular β/A4 amyloidosis is also prevalent in the disease. The mechanism by which β/A4 amyloid accumulates in the AD brain is unknown. Recent research has demonstrated that the precursor molecule, APP, is a transmembrane protein with a large extracytoplasmic domain, a membrane spanning region that includes the portion that gives rise to β/A4 amyloid, and a short intracytoplasmic domain. The precursor has multiple forms among which are those that differ by a variable length insert within the extracytoplasmic domain. The insert has sequence homology to the family of Kunitz protease inhibitor proteins. Cellular and animal models have been developed to study the nature of APP processing and the biological and behavioral consequences of β/A4 amyloidosis. The results of such studies indicate that the normal processing of APP involves enzymatic cleavage of the molecule within the β/A4 amyloid region, thus preventing the accumulation of β/A4 in the normal brain. The factors leading to abnormal processing of APP, and consequent β/A4 amyloid accumulation within the AD brain, have yet to be identified. In cell culture, the biological effects associated with β/A4 amyloid include neurotrophic and neurotoxic activities, while the peptide has also been shown to have dramatic behavioral effects in animal models.
Similar content being viewed by others
References
Allsop, D., Landon, M., Kidd, M., Lowe, J.S., Reynolds, G.P., Gardner, A. (1986). Monoclonal antibodies raised against a subsequence of senile plaque core protein react with plaque cores, plaque periphery, and cerebrovascular amyloid in Alzheimer’s disease. Neurosci. Lett. 68:252–256
Allsop, D., Wong, C.W., Ikeda, S.I, Landon, M., Kidd, M., Glenner, G.G. (1988). Immunohistochemical evidence for the derivation of a peptide ligand from the amyloid β-protein precursor of Alzheimer’s disease. Proc. Natl. Acad. Sci. U.S.A. 85:2790–2794
Anderton, B.H., Brion, J.P., Flament-Durand, J., Haugh, M.C., Kahn, J., Miller, C.L., Probst, A., Ulrich, J. (1987). Neurofibrillary tangles and the neuronal cytoskeleton. J. Neural Transm Suppl. 24:191–196
Autillio-Gambetti, L., Morandi, A., Tabaton, M., Schaetzle, B., Kovaks, D., Perry, G., Greenberg, B., Gambetti, P. (1988). The amyloid precursor protein of Alzheimer disease is expressed as a 130 kDa polypeptide in various cultured cell types. FEBS Lett. 241:94–98
Bahmanyar S., Higgins, G., Goldgaber, D., Lewis, D.A., Morrison, J.H., Wilson, M.C., Shankar, S.K., Gajdusek, D.C. (1987). Localization of amyloid β protein messenger RNA in brains from patients with Alzheimer’s disease. Science 237:77–80
Barrow, C.J., Zagorski, M.G. (1991). Solution structures of β peptide and its constituent fragments: Relation to amyloid deposition. Science 253:179–182
Benes, F.M., Reifel, J.L., Majocha, R.E., Marotta, C.A. (1989). Evidence for diffusion of Alzheimer amyloid A4 (β-amyloid) epitope during neuritic plaque formation. Neuroscience 33:483–488
Benes, F.M., Farol, P.A., Majocha, R.E., Marotta, C.A. (1991). Evidence for destruction of axons within regions occupied by senile plaques in Alzheimer cortex. Neuroscience 42:651–660
Bothwell, M.L., Shooter, E.M. (1978). Thermodynamics of interaction of the subunits of 7 S nerve growth factor. The mechanism of activation of the esteropeptidase activity by chelators. J. Biol. Chem. 253:8458–8464
Buxbaum, J.D., Gandy, S.E., Cicchetti, P., Ehrlich, M.E., Czernik, A.J., Fracasso, R.P., Ramabhadran, T.V., Unterbeck, A.J., Greengard, P. (1990). Processing of Alzheimer beta/A4 amyloid precursor protein: Modulation by agents that regulate protein phosphorylation. Proc. Natl. Acad. Sci. USA 87:6003–6006
Card, J.P., Meade, R.P., Davis, L.G. (1988). Immunocytochemical localization of the precursor protein for β-amyloid in the rat central nervous system. Neuron 9:835–846
Castano, E.M., Ghiso, J., Prelli, F., Gorevic, P.D., Migheli, A., Frangione, B. (1986). In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer’s disease β-protein. Biochem. Biophys. Res. Commun. 141: 782–789
Chou, W.G., Majocha, R.E., Sajdel-Sulkowska, E.M., Benes, F.M., Salim, M., Stoler, M., Fulwiler, C.E., Ventosa-Michelman, M., Rodenrys, A.M., Moore, K.E., Webb, T., Zain, S.B., Marotta, C.A. (1988). Immunologic and molecular genetic studies on amyloid deposition in the Alzheimer’s disease brain. Brain Dysfunct. 1:133–145
Chou, W.-G., Zhu, W., Salim, M., Rehman, S., Tate-Ostroff, B., Majocha, R.E., Sajdel-Sulkowska, E.M., Marotta, C.A., Zain, S.B. (1989). Extracytoplasmic and A4 domains of the amyloid precursor protein: Molecular cloning, genetically engineered cell lines and immunocytochemical investigations. Alzheimer’s Disease and Related Disorders. K. Iqbal, H.M. Wisniewski, B. Winblad (eds). Alan R. Liss, New York, pp 991–999
Chou, W.G., Zain, S.B., Rehman, S., Tate-Ostroff, B., Majocha, R.E., Benes, F.M., Marotta, C.A. (1990). Alzheimer cortical neurons containing abundant amyloid mRNA. Relationship to amyloid deposition and senile plaques. J. Psychiatr. Res. 24:37–50
Cohen, M.L., Golde, T.E., Usiak, M.F., Younkin, L.H., Younkin, S.G. (1988). In situ hybridization of nucleus basalis neurons shows increased β-amyloid mRNA in Alzheimer’s disease. Proc. Natl. Acad. Sci. U.S.A. 85:1227–1231
Coyle, J.T., Price, D.L., DeLong, M.R. (1983). Alzheimer’s Disease: A disorder of cortical cholinergic innervation. Science 219:1184–1190
Crowther, R.A., Wischik, C.M. (1985). Image reconstruction of the Alzheimer paired helical filament. EMBO J 4:3661–3665
Davies, P., Maloney, A.J.F. (1980). Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet 2:1403
Davies, P., Katzman, R., Terry, R.D. (1980). Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer’s disease. Nature 288:279–280
de Sauvage, F., Octave, J.N. (1989). A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein. Science 245:651–653
Divry, P. (1927). Etude histo-chimique des plaques senile. J. Neurol. Psych. 27:643–657
Doyle, E., Bruce, M.T., Breen, K.C., Smith, D.C., Anderton, B., Regan, C.M. (1990). Intraventricular infusions of antibodies to amyloid-β-protein precursor impair the acquisition of a passive avoidance response in the rat. Neurosci. Lett. 115:97–102
Dyrks, J.D., Weidemann, A., Multhaup, G., Salbaum, J.M., Lamaire, H.G., Kang, J., Muller-Hill, B., Masters, C.L., Beyreuther, K. (1988). Identification transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer’s Disease. EMBO J. 7:949–957
Esch, F.S., Keim, P.S., Beattie, E.C., Blacher, R.W., Culwell, A.R., Oltersdorf, T., McClure, D., Ward, P.J. (1990). Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248:1122–1124
Flood, J.F., Morley, J.E., Roberts, E. (1991). Amnestic effects in mice of four synthetic peptides homologous to amyloid β protein from patients with Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 88:3363–3366
Friedland, R.P., Budinger, T.F., Ganz, E., Yano, Y., Mathis, C.A., Koss, B., Ober, B.A., Huesman, R., Derenzo, S. (1983). Regional cerebral metabolic alterations in dementia of the Alzheimer-type: Positron emission tomography with 18-fluorodeoxyglucose. J. Comput. Assist. Tomogr. 7:590–589
Glenner, G.G. (1980). Amyloid deposits and amyloidosis. The β-fibrilloses. N. Engl. J. Med. 302:1333–1343
Glenner, G.G., Wong, C.W. (1984a). Alzheimer’s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:885–890
Glenner, G.G., Wong, C.W. (1984b). Alzheimer’s disease and Down’s syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122:1131–1135
Glenner, G.G., Henry, J.H., Fujihara, S. (1981). Congophilic angiopathy in the pathogenesis of Alzheimer’s degeneration. Ann. Pathol. 1:120–129
Goate, A., Chartier-Harlin, M.-C., Mullan, M.L., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., Mant R., Newton, P., Rooke, K., Roques, P., Talbot, C., Pericak-Vance, M., Roses, A., Williamson, R., Rossor, M., Owen, M., Hardy, J. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349:704–706
Gode, T.E., Estus, S., Usiak, M., Younkin, L.H., Younkin, S.G. (1990). Expression of β amyloid protein precursor mRNA: Recongnition of a novel alternatively spliced form and quantitation in Alzheimer’s disease using PCR. Neuron 4:253–267
Goedert, M. (1987). Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer’s disease. EMBO J. 6:3627–3632
Goldgaber, D., Lerman, M.I., McBride, O.W., Saffiotti, U., Gajdusek, D.C. (1987). Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer’s disease. Science 235:877–880
Gorevic, P.D., Castano, E.M., Sarma, S., Frangione, B. (1987). Ten to fourteen residue peptides of Alzheimer’s disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern. Biochem. Biophys. Res. Commun. 147:854–862
Greene, L.A., Tischler, A.S. (1976). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U.S.A. 73:2424–2428
Greenwald, B.S., Mohs, R.C., Davis, K.L. (1983). Neurotransmitter deficits in Alzheimer’s Disease: Criteria for significance. J. Am. Geriatr. Soc. 31:310–316
Guiroy, D.C., Miyazaki, M., Multhaup, G., Fischer, P., Garruto, R.M. Beyreuther, K., Masters, C.L., Simms, G., Gibbs, C.J., Gajdusek, D.C. (1987). Amyloid of neurofibrillary tangles of Guamanian parkinsonism-dementia and Alzheimer disease share identical amino acid sequence. Proc. Natl. Acad. Sci. U.S.A. 84:2073–2977
Hart, R.P., Kwentus, J.A., Harkins, S.W., Taylor, J.R. (1988). Rate of forgetting in mild Alzheimer’s type dementia. Brain Cogn. 7:31–38
Hay, J.W., Ernst, R.L. (1987). The economic costs of Alzheimer’s disease. Am. J. Pub. Health 77:1169–1175
Higgins, G.A., Lewis, D.A., Bahmanyar, S., Goldgaber, D., Gajdusek, D.C., Young, W.G., Morrison, J.H., Wilson, M.C. (1988). Differential regulation of amyloid-β-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 85:1297–1301
Higgins, G.A., Oyler, G.A., Neve, R.L., Chen, K.S., Gage, F.H. (1990). Altered levels of amyloid protein precursor transcripts in the basal forebrain of behaviorally impaired aged rats. Proc. Natl. Acad. Sci. U.S.A. 87:3032–3036
Hyman, B.T., VanHoesen, G.W., Damasio, A.R., Barnes, C.L. (1984). Alzheimer’s disease: Cell specificity pathology isolates the hippocampal formation. Science 225:1168–1170
Ishii, N., Nishihara, Y., Horie, A. (1983). Lobar cerebral hemorrhage and amyloid angiopathy: A report of 4 autopsy cases. No To Shinkei Brain and Nerve 35:167–174
Ishiura, S. (1991). Proteolytic cleavage of the Alzheimer’s disease amyloid A4 precursor protein. J. Neurochem. 56:363–369
Kang, J., Muller-Hill, B. (1990). Differential splicing of Alzheimer’s disease amyloid A4 precursor RNA in rat tissues: preA4 695 mRNA is predominantly produced in rat and human brain. Biochem. Biophys. Res. Commun. 166:1192–1200
Kang, J., Lemaire, J.G., Unterbeck, A., Salbaum, J.M., Masters, C.L., Grzeschik, K.H., Multhaup, G., Beyreuther, K., Muller-Hill, B. (1987). The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733–736
Katzman, R. (1986). Alzheimer’s Disease. N. Engl. J. Med. 314:964–973
Katzman, R., Saitoh, R. (1991). Advances in Alzheimer’s disease. FASEB J. 5:278–286
Kidd, M. (1963). Paired belical filaments in electron microscopy in Alzheimer disease. Nature 197:192–193
Kirschner, D.A., Abraham, C., Selkoe, D.J. (1986). X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. Proc. Natl. Acad. Sci. U.S.A. 83:503–507
Kitaguchi, N., Takahashi, Y., Tokushima, Y., Shiojiri, S., Ito, H. (1988). Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity. Nature 331:531–534
Knauer, D.J., Scaparro, K.M., Cunningham, D.D. (1982). The gamma subunit of 7S nerve growth factor binds to cells via complexes formed with two-cell-secreted nexins. J. Biol. Chem. 257:15098–15104
Knauer, D.J., Thompson, J.A., Cunningham, D.D. (1983). Protease nexins: Cell-secreted proteins that mediate the binding, internalization, and degradation of regulatory serine proteases. J. Cell Physiol. 117:385–396
Kosik, K.S. (1991). Alzheimer plaques and tangles: advances on both fronts. Trends Neurosci. 14:218–219
Koss, E., Friedland, R.P., Ober, B.A., Jagust, W.J. (1985). Differences in lateral hemispheric asymmetries of glucose utilization between early and late-onset Alzheimer-type dementia. Am. J. Psychiatry 142:638–640
Landon, M., Kidd, M. (1989). Amyloid in Alzheimer’s disease. Biochem. Soc. Trans. 17:69–72
Lee, S., Stemmerman, G.N. (1978). Congophilic angiopathy and cerebral hemorrhage. Arch. Pathol. Lab Med. 102:317–328
Lee, V., Balin, B.J., Otvos, L., Jr., Trojanowski, J.Q. (1990). A68: A major subunit of paired helical filaments and derivatized forms of normal tau. Science 251:675–678
Lemaire, H.G., Salbaum, J.M., Multhaup, G., Kang, J., Bayney, R.M., Unterbeck, A., Beyreuther, K., Muller-Hill, B. (1989). The preA4 (695) precursor protein of Alzheimer’s disease A4 amyloid is encoded by 16 exons. Nucleic Acids Res. 17:517–522
Levy, E., Carman, M.D., Fernandez-Madrid, I.J., Power, M.D., Lieberburg, I., van Duinen, S.G., Gerard, T., Bots, A.M., Luyendijk, W., Frangione, B. (1990). Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124–1128
Lewis, D.A., Higgins, G.A., Young, W.G., Goldgaber, D., Gajdusek, D.C., Wilson, M.C., Morrison, J.H. (1988). Distribution of precursor amyloid-beta-protein messenger RNA in human cerebral cortex: Relationship to neurofibriliary tangles and neuritic plaques. Proc. Natl. Acad. Sci. U.S.A. 85:1691–1695
Lishman, A. (1978). Organic Psychiatry. Blackwell, London
Love, S., Saitoh, T., Quijada, S., Cole, G.M., Terry, R.D. (1988). Alz 50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J. Neuropathol. Exp. Neurol. 47:393–405
Luo, L., Martin-Morris, L.E., White, K. (1990). Identification, secretion, and neural expression of APPL, aDrosophila protein similar to human amyloid protein precursor. J. Neurosci. 10:3849–3861
Majocha, R.E., Benes, F.M., Reifel, J.L., Rodenrys, A.M., Marotta, C.A. (1988). Laminar-specific distribution and infrastructural detail of amyloid in the Alzheimer cortex visualized by computer-enhanced imaging of unique epitopes. Proc. Natl. Acad. Sci. U.S.A. 85:6182–6186
Majocha, R.E., Tate, B., Ventosa-Michelman, M., Marotta, C.A. (1991). Characterization of neurite-stimulating activity from conditioned media of transfected PC12 cells that overexpress β/A4-amyloid. Soc. Neurosci. 17:1105
Mandybur, T.I. (1975). The incidence of cerebral amyloid angiopathy in Alzheimer’s disease. Neurology 25:20–126
Marotta, C.A. (1984). Neuronal intermediate filaments. Handbook of Neurochemistry, Vol 7, A. Lajtha (ed). Plenum Press, New York, pp 305–309
Marotta, C.A., Majocha, R.E., Coughlin, J.E., Manz, H.J., Davies, P., Ventosa-Michelman, M., Chou, W.G., Zain, S.B., Sajdel-Sulkowska, E.M. (1986). Transcriptional and translational regulatory mechanisms during normal aging of the mammalian brain and in Alzheimer’s disease. Proc. Brain Res. 70:303–320
Marotta, C.A., Chou, W.-G., Majocha, R.E., Watkins, R., Zain, S.B. (1989a). Overexpression of amyloid precursor protein A4 (β-amyloid) immunoreactivity in genetically transformed cells. Implications for a cellular model of Alzheimer amyloidosis. Proc. Natl. Acad. Sci. U.S.A. 86:337–341
Marotta, C.A., Walcott, E>C., Tate-Ostroff, B., Majocha, R.E. (1989b). Immunocytochemical studies of brain and PC12 cells using antibodies to the amyloid precursor protein. Soc. Neurosci. 15:1375
Masters, C.L., Multhaup, G., Simms, G., Pottgiesser, J., Martins, R.M., Beyreuther, K. (1985a). Neuronal origin of a cerebral amyloid: Neurofibrillary tangles of Alzheimer’s disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J. 4:2757–2763
Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L., Beyreuther, I. (1985b). Amyloid plaque core protein in Alzheimer’s disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 82:4245–4249
McGeer, E.G., Singh, E.A., McGeer, P.L. (1987). Gamma-glutamyltransferase: Normal cortical levels in Alzheimer disease. Alzheimer Dis. Assoc. Disorders 1:38–42
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E.M. (1984). Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of the DHHS Task Force on Alzheimer’s disease. Neurology 34:939–944
Merz, P.A., Wisniewski, H.M., Somerville, R.A., Bobin, S.A., Masters, C.L., Iqbal, K. (1983). Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques. Acta Neuropathol. 60:113–124
Mobley, W.C., Neve, R.L., Prusiner, S.B., McKinley, M.P. (1988). Nerve growth factor increases mRNA levels for the prion protein and the β-amyloid protein precursor in developing hamster brain. Proc. Natl. Acad. Sci. U.S.A. 85:9811–9815
Mortimer, J.A., French, L.R., Hutton, J.T., Schuman, L.M. (1985). Head injury as a risk factor for Alzheimer’s disease. Neurology 35:264–267
Mountjoy, C.Q., Tomlinson, B.E., Gibson, P.H. (1982). Amyloid and senile plaques and cerebral blood vessels. A semi-quantitative investigation of a possible relationship. J. Neurol. Sci. 57:89–102
Mountjoy, C.Q., Roth, M., Evans, N.J.R., Evans, H.M. (1983). Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol. Aging 4:1–11
Moss, A., Albert, M., Butters, N., Payne, M. (1986). Differential patterns of memory loss among patients with Alzheimer’s disease, Huntington’s disease and alcoholic Korsakoff’s syndrome. Arch. Neurol. 43:239–246
Nikina, N. (1989). The reinterpretation of the immunochemical study of Alzheimer neurofibrillary tangles. Ann. Med. 21:117–119
Oltersdorf, T., Fritz, L.C., Schenk, D.B., Lieberburg, I., Johnson-Wood, K.L., Beattie, E.C., Ward, P.J., Blacher, R.W., Dovey, H.F., Sinha, S. (1989). The secreted form of Alzheimer’s amyloid precursor protein with the Kunidz domain is protease nexin-II. Nature 341:144–147
Palmert, M.R., Golde, T.E., Cohen, M.L., Kovacs, D.M., Tanzi, R.E., Gusella, J.G., Usiak, M.F., Younkin, L.H., Younkin, S.G. (1988). Amyloid protein precursor messenger RNAs: Differential expression in Alzheimer’s disease. Science 241:1080–1084
Palmert, M.R., Podlisny, M.B., Witker, D.S., Oltersdorf, T., Younkin, L.H., Selkoe, D.J., Younkin, S.G. (1989a). The β-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid. Proc. Natl. Acad. Sci. U.S.A. 86:6338–6342
Palmert, M.R., Siedlak, S.L., Berman-Podisny, M., Greenbert, B., Shelton, E.R., Chan, H.W., Usiak, M., Selkoe, D.J., Perry, G., Younkin, S.G. (1989b). Soluble derivatives of the β amyloid protein precursor of Alzheimer’s disease are labeled by antisera to the amyloid protein. Biochem. Biophys. Res. Commun. 165:182–188
Perl, D.P., Brody, A.R. (1980). Alzheimer’s disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science 208:297–299
Perry, E.K. (1980). The cholinergic system in old age and Alzheimer’s disease. Age Ageing 9:1–8
Perry, E.K. (1990). Nerve growth factor and the basal forebrain cholinergic system: A link in the etiopathology of neurodegenerative dementias? Alzheimer Dis. Assoc. Disorders 4:1–13
Ponte, P., Gonzalez-DeWhitt, P., Schilling, J., Miller, J., Hsu, D., Greenberg, B., Davis, K., Wallace, W., Lieberburg, I., Fuller, F., Cordell, B. (1988). A new A4 amyloid mRNA contains a domain homologous to serine protease inhibitors. Nature 331:525–527
Price, D.L. (1986). New perspectives on Alzheimer’s disease. Annu. Rev. Neurosci. 9:489–512
Pro, J.D., Smith, C.H., Sumi, S.M. (1980). Presenile Alzheimer disease: Amyloid plaques in the cerebellum. Neurology 30:820–825
Ranalli, P., Bergeron, C. (1984). Amyloid angiopathy in Alzheimer’s disease. Ann. Neurol. 16:119–127
Quom, D., Wang, Y., Catalano, R., Scardina, J.M., Murakami, K., Cordell, B. (1991). Formation of β-amyloid protein deposits in brains of transgenic mice. Nature 352:239–241
Refolo, L.M., Salton, S.R., Anderson, J.P., Mehta, P., Robakis, N.K. (1989). Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC 12 cell cultures. Biochem. Biophys. Res. Commun. 164:664–670
Robakis, N.K., Ramakrishna, N., Wolfe, G., Wisniewski, H.M. (1987). Molecular cloning and characterization of a cDNA encoding the cerebrovascular and neuritic plaque amyloid peptides. Proc. Natl. Acad. Sci. U.S.A. 84:4190–4194
Roher, A.E., Ball, M.J., Bhave, S.V., Wakade, A.R. (1991). β-Amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons. Biochem. Biophys. Res. Commun. 174:572–579
Rozenmuller, J.M., Eikelenboom, P., Kamphorst, W., Stam, F.C. (1988). Lack of evidence for dysfunction of the blood-brain barrier in Alzheimer’s disease: An immunohistochemical study. Neurobiol. Aging 9:383–391
Rumble, B., Retallack, R., Hilbich, C., Simms, G., Multhaup, G., Martins, R., Hockey, A., Montgomery, P., Beyreuther, K., Masters, C.L. (1989). Amyloid A4 protein and its precursor in Down’s syndrome and Alzheimer’s disease. N. Engl. J. Med. 320:1446–1452
Rudelli, R.D., Wisniewski, H.M. (1985). Cerebellar amyloid plaques in Alzheimer’s dementia and senile dementia of the Alzheimer type: Morphology and distribution. J. Neuropathol. Exp. Neurol. 44:364
Saitoh, T., Sundsmo, M., Roch, J.-M., Kimura, N., Cole, G., Schubert, D., Oltersdorf, T., Schenk, D.B. (1989). Secreted form of amyloid β protein precursor is involved in growth regulation of fibroblasts. Cell 58:615–622
Salim, M., Zain, S.B., Chou, W.G., Saidel-Sulkowska, E.M., Majocha, R.E., Rehman, S., Benes, F.M., Marotta, C.A. (1988). Molecular cloning of amyloid cDNA from Alzheimer brain messenger RNA. Correlative neuroimmunologic and in situ hybridization studies. Familial Alzheimer’s Disease Molecular Genetics, Clinical Prospects and Societal Issues. J.P. Blass, G.D. Miner, L.A. Miner, R.W. Richter and J.L. Valentine (eds), Marcel Dekker, New York, pp 153–165
Sasaki, H., Muramoto, O., Kanazawa, I., Arai, H., Kosaka, K., Iizuka, R. (1986). Regional distribution of amino acid transmitters in postmortem brains and presenile and senile dementia of Alzheimer type. Ann. Neurol. 19:263–269
Schellenberg, G.D., Bird, T.D., Wiseman, E.M., Moore, D.K., Boehnke, M., Bryant, E.M. Lampe, T.H., Nochlin, D., Sumi, S.M., Deeb, S.S., Beyreuther, K., Martin, G.M. (1988). Absence of linkage of chromosome 21q21 markers to familial Alzheimer’s disease. Science 241:1507–1510
Schubert, D., Cole, G., Saitoh, T., Oltersdorf, T. (1989). Amyloid beta protein precursor is a mitogen. Biochem. Biophys. Res. Commun. 162:83–88
Shivers, B., Hilbich, C., Multhaup, G., Salbaum, J.M., Beyreuther, K., Seeburg, P.H. (1988). Alzheimer’s disease amyloidogenic glycoprotein: Expression pattern in rat brain suggests a role in cell contact. EMBO J. 7:1365–1370
Sisodia, S.S., Koo, E.H., Beyreuther, K., Unterbeck, A., Price, D.L. (1990). Evidence that β-amyloid protein in Alzheimer’s disease is not derived by normal processing. Science 248:492–495
St. George-Hyslop, P.H., Tanzi, R.E., Pollinsky, R.J., Haines, J.L., Nee, L., Watkins, P.C. (1990a). The genetic defect causing familial Alzheimer’s disease maps on chromosome 21. Science 235:885–890
St. George-Hyslop, P.H., Haines, J.L., Farrer, L.A., Polinsky, R., Van Broeckhoven, C., Goate, A., McLachlan, D.R., Orr, H., Bruni, A.C., Sorbi, S., Rainero, I., Foncin, J.-F., Pollen, D., Cantu, J.-M., Tupler, R., Voskresenskaya, N., Mayeux, R., Growdon, J., Fried, V.A., Myers, R.H., Nee, L., Backhovens, H., Martin, J.-J., Rossor, J., Owen, M.J., Mullan, M., Percy, M.E., Karlnsky, J., Rich, S., Heston, L., Montesi, M., Mortilla, M., Nacmeas, M., Gusella, J.F., Hardy, J.A., members of the FAD Collaborative Study Group (1990b). Genetic linkage studies suggest that Alzheimer’s disease is not a single homogeneous disorder. Nature 347:194–197
Tagawa, K., Kunishita, K., Maruyama, K., Kazuaki, Y., Kominami, E., Tsuchiya, T., Suzuki, K., Tabira, T., Sugita, H., Ishiura, S. (1991). Alzheimer’s disease amyloid β-clipping enzyme (APP secretase): Identification, purification and characterization of the enzyme. Biochem. Biophys. Res. Commun. 177:377–387
Tanzi, R.E., Gusella, J.F., Watkins, P.C., Gruns, G.A.P., St. George-Hyslop, P., VanKeuren, M.L., Patterson, D., Pagan, S., Kurnit, D.M., Neve, R.L. (1987a). Amyloid β protein gene: cDNA, mRNA cistribution and genetic linkage near the Alzheimer locus. Science 235:880–884
Tanzi, R.E., St. George-Hyslop, P.H., Haines, J.L., Polinsky, R.J., Nee, L., Foncin, J.-F., Neve, R.L., McClatchey, A.I., Conneally, P.M., Gusella, J.F. (1987b). The genetic defect in familial Alzheimer’s disease is not tightly linked to the amyloid β-protein gene. Nature 329:156–157
Tanzi, R.E., McClatchey, A.I., Lamperti, E.D., Villa-Komaroff, L., Gusella, J.F., Neve, R.L. (1988). Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer’s disease. Nature 331:528–530
Tate, B., Aboody, K.S., Morris, A.M., Majocha, R.E., Marotta, C.A. (1991). Alterations in the circadian rhythms of rats receiving SCN implants of PC12 cells overexpressing Alzheimer’s disease β-amyloid. Soc. Neurosci. 17:1066
Tate-Ostroff, B., Majocha, R.E., Marotta, C.A. (1989a). Identification of cellular and extracellular sites of amyloid precursor protein extracytoplasmic domain in normal and Alzheimer brains. Proc. Natl. Acad. Sci. U.S.A. 86:745–749
Tate-Ostroff, B., Walcott, E.C., Paskevich, P., Zain, S.B., Chou, W.G., Majocha, R.E., Marotta, C.A. (1989b). Morphological and immunological studies of PC12 cells transfected with the β-amyloid region of the amyloid precursor protein. Soc. Neurosci. 15:654
Tate-Ostroff, B., Majocha, R.E., Walcott, E.C., Ventosa-Michelman, M., Marotta, C.A. (1990). Colocalization of amino terminal and A4 (β-amyloid) antigens in Alzheimer plaques: Evidence for coordinated processing of the amyloid precursor protein. J. Geriatr. Psychiatry Neurol. 3:139–145
Tomlinson, B.E., Corsellis, J.A.N. (1984). Ageing and the dementias. Greenfield’s Neuropathology, ed 4. J.H. Adams, H.A.N. Corsellis, L.W. Duchen (eds). John Wiley & Sons, New York, pp 951–1006
Van Broeckhoven, C., Haan, J., Bakker, E., Hardy, J.A., Van Hul, W., Wehnert, A., Vegter-Van der Vlis, M., Roos, R.A.C. (1990). Amyloid β protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 248:1120–1122
Van Nostrand, W.E., Wagner, S.L., Suzuki, M., Choi, B.H., Farrow, J.S., Geddes, J.W., Cotman, C.W., Cunmingham, D.D. (1989). Protease nexin-II, a potent anti-chymotrypsin, shows identity to amyloid β-protein precursor. Nature 341:546–549
Vinters, H.V. (1987). Cerebral amyloid angiopathy: A critical review. Stroke 18:311–324
Vitek, M.P., Rasool, C.G., de Sauvage, F., Vitek, S.M., Bartus, R.T., Beer, B., Ashton, R.A., Macq, A.-F., Maloteaux, J.M., Blume, A.J., and Octave, J.-N., (1988). Absence of mutation in the beta-amyloid cDNAs cloned from the brains of three patients with sporadic Alzheimer’s disease. Brain Res. 464:121–131
Weidemann, A., Köning, G., Bunke, D., Fischer, P., Salbaum, M.J., Masters, C.L., Beyreuther, K. (1989). Identification, biogenesis and localization of precursors of Alzheimer’s disease A4 amyloid protein. Cell 57:115–126
Wells, C.E. (1977) Diagnostic evaluation and treatment in dementia. Dementia, 2nd ed. C.M. Wells (ed). F.A. Davis, Philadelphia, pp 247–276
Whitson, J.S., Selkoe, D.J., Cotman, C.W. (1989). Amyloid β protein enhances the survival of hippocampal neurons in vitro. Science 243:1488–1490
Whitson, J.S., Glabe, C.G., Shintani, E., Abcar, A., Cotman, C.W. (1990). β-Amyloid protein promotes neuritic branching in hippocampal cultures. Neurosci. Lett. 110:319–324
Wion, D., Le Bert, M., Brachet, P. (1988). Messenger RNAs of β-amyloid precursor protein and prion protein are regulated by nerve growth factor in PC12 cells. Int. J. Dev. Neurosci. 6:387–393
Wirak, D.O., Bayney, R., Ramabhadran, T.V., Fracasso, R.P., Hart, J.T., Hauer, P.E., Hsiau, P., Pekar, S.K., Scangos, G.A., Trapp, B.D., Unterbeck, A.J. (1991). Deposits of amyloid β protein in the central nervous system of transgenic mice. Science 253:323–325
Wischik, C.M., Crowther, R.A., Stewart, M., Roth, M. (1985). Subunit structure of paired helical filaments in Alzheimer’s disease. J. Cell Biol. 100:1905–1912
Wischik, C.M., Novak, M., Edwards, P.C., Klug, A., Tichelar, A. (1988). Structural characterization of the core of the paired helical filament. Proc. Natl. Acad. Sci. U.S.A. 85:4884–4888
Wisniewski, H.M., Terry, R.D. (1973). Reexamination of the pathogenesis of the senile plaque. Progress in Neuropathology. H.M. Zimmerman (ed). Grune and Stratton, New York, pp 1–26
Wisniewski, H.M., Kozlowski, P.B. (1982). Evidence for blood-brain barrier changes in senile dementia of the Alzheimer type (SDAT). Ann. N.Y. Acad. Sci. 396:119–189
Wisniewski, H.M., Narang, J.K., Terry, R.D. (1976). Neurofibrillary tangles of paired helical filaments. J. Neurol. Sci. 27:173–181
Wisniewski, H.M., Moretz, R.C., Lossinsky, A.S. (1981). Evidence for induction of localized amyloid deposits and neuritic plaques by an infectious agent. Ann. Neurol. 10:517–522
Wong, C.W., Quaranta, V., Glenner, G.G. (1985). Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc. Natl. Acad. Sci. U.S.A. 82:8729–8732
Yamada, T., Sasaki, H., Furuya, H., Miyata, T., Goto, I., Sakaki, Y. (1987). Complementary DNA for the mouse homolog of the human amyloid beta protein precursor. Biochem. Biophys. Res. Commun. 149:665–671
Yankner, B.A., Villa-Komaroff, L., Neve, R.L. (1988). The biological activity of Alzheimer’s amyloid. Soc. Neurosci. 14:896 (abstract)
Yankner, B.A., Dawes, L.R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M.L., Neve, R. (1989). Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer’s disease. Science 245:417–420
Yankner, B.A., Duffy, L.K., Kirschner, D.A. (1990). Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 250:279–282
Zain, S.B., Salim, M., Chou, W.-G., Sajdel-Sulkowska, E.M., Majocha, R.E., Marotta, C.A. (1988). Molecular cloning of amyloid cDNA derived from mRNA of the Alzheimer brain. Coding and non-coding regions of the fetal precursor mRNA are expressed in the Alzheimer cortex. Proc. Natl. Acad. Sci. U.S.A. 85:929–933
Zain, S.B., Chou, W.G., Majocha, R.E., Ventosa-Michelman, M., Marotta, C.A. (1989). Genetically engineered cells that overexpress amyloid A4 (beta amyloid) of Alzheimer disease. American Association of Neuropathologists Annual Meeting abstract 103. J. Neuropathol. Exp. Neurol. 48:335
Zimmerman, K., Herget, T., Salbaum, J.M., Schubert, A., Hilbich, C., Cramer, M., Masters, C.L., Multhaup, G., Kang, J., Lamaire, H.G. (1988). Localization of the putative precursor of Alzheimer’s disease-specific amyloid at nuclear envelopes of adult human muscle. EMBO J. 7:367–372
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marotta, C.A., Majocha, R.E. & Tate, B. Molecular and cellular biology of Alzheimer amyloid. J Mol Neurosci 3, 111–125 (1992). https://doi.org/10.1007/BF02919403
Issue Date:
DOI: https://doi.org/10.1007/BF02919403